Innocoll is dedicated to making better happen _ striving to engineer better medicines to transform todayÍs treatment approaches.
Our proprietary, biocompatible, and biodegradable collagen-based products are engineered for targeted use. Applied locally, they are designed to provide a range of treatment benefits.
Our late-stage product pipeline is focused on addressing the significant unmet medical need for postsurgical pain management. XARACOLL, a bupivacaine HCI collagen-matrix implant, has been studied in two Phase III clinical trials for postsurgical analgesia as a part of multi-modal therapy for patients undergoing hernia repair.
Our currently approved products include: COLLAGUARD¬ (ex-US), COLLATAMP¬ G, SEPTOCOLL¬ E, REGENEPRO¬, COLLACARE¬, COLLEXA¬, and ZORPREVA¬, some of which are sold globally through strategic partnerships. All of our collagen products„from extraction/purification of Type 1 collagen through final delivery„ are manufactured at our certified, integrated plant in Saal, Germany.
- Company Name:Spi
(View Trends)
-
Headquarters: (View Map)Athlone, Ireland
-
50 - 200 employees
- 29063187 Global Rank
- 6803192 Germany
-
Search100.00%
-
Direct0.00%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
-
Social0.00%
![](https://d2msby6dr6c92m.cloudfront.net/assets/similar-web-d795926c93666fae2318ea9a54f39ba58f506fd2065875b501c4f2682992c700.png)
- India 95.7%
- United States 0.8%
- United Arab Emirates 0.5%
- Qatar 0.4%
- Senior Health